Effects of Endocrine Disruptors on Developmental and Reproductive Functions
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
1-10
Author(s):
Tiziana A. L.Brevini, Simona Bertola Zanetto and Fabiana Cillo
Mitochondrial Trifunctional Protein Defects: Molecular Basis and Novel Therapeutic Approaches
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
27-40
Author(s):
J. Angdisen, V. D.G. Moore, J. M. Cline, R. M. Payne and J. A. Ibdah
Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
115-130
Author(s):
Mohanraj Dhanabal, Mike Jeffers and William J. LaRochelle
Activation of p53 by Specific Agents in Potential Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
131-135
Author(s):
John W. Ho, Jing Zheng Song and Yuet Kin Leung
Medicinal Properties of Neem Leaves: A Review
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
149-156
Author(s):
R. Subapriya and S. Nagini
Novel Biological Agents for the Treatment of Hormone-Refractory Prostate Cancer (HRPC)
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
277-296
Author(s):
A. G. Papatsoris, M. V. Karamouzis and A. G. Papavassiliou
Gene Therapy Strategies in Prostate Cancer
Journal:
Current Gene Therapy
Volume:
5
Page:
1-10
Author(s):
Iris E. Eder, Petra Haag, Georg Bartsch and Helmut Klocker
Synthetic Hammerhead Ribozymes as Therapeutic Tools to Control Disease Genes
Journal:
Current Gene Therapy
Volume:
5
Page:
11-24
Author(s):
L. Citti and G. Rainaldi
Retroviral Gene Therapy: Safety Issues and Possible Solutions
Journal:
Current Gene Therapy
Volume:
5
Page:
25-35
Author(s):
Youngsuk Yi, Sung Ho Hahm and Kwan Hee Lee
In Situ Gene Therapy for Prostate Cancer
Journal:
Current Gene Therapy
Volume:
5
Page:
111-119
Author(s):
Takefumi Satoh, Akira Irie, Shin Egawa and Shiro Baba